Health Condition 1: null- Patients with maxillofacial trauma
Conditions
Interventions
Intervention1: Drug Cissus Quadrangularis 400mg: Oral administration of Two tablets of tab Ciss Q Twice daily for 3 months following trauma
Control Intervention1: Nil: Nil
Sponsors
Aksigen Hospital Care
Eligibility
Inclusion criteria
Inclusion criteria: Patients with any form of maxillofacial fractures of either sex planning to manage by conservative method. Age group 20-60 years. Patients who are willing to participate in the study and come for follow up
Exclusion criteria
Exclusion criteria: Patients presenting with facial fractures undergoing open reduction and internal fixation. Patients with any systemic diseases. Patients with endocrine disturbances. Patients with anomalies of the blood and immune system, bone disorders. Patients taking drugs that affect bone metabolism. Infected fractures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of the Drug Cissus Quadrangularis in healing of facial fractures as documented in literature. Previous literature suggests that the healing of the fracture is accelerated when treated with Drug Cissus Quadrangularis as it possess, osteoblastic,antibacterial, antifungal, antioxidant, anthelmintic, antihemorrhoidal and analgesic activities.Timepoint: 3 months following trauma | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the changes in the blood biochemical valuesTimepoint: one month following trauma | — |
Countries
India
Contacts
Public ContactDrChithra Aramanadka
Manipal College of Dental Sciences,Manipal
Outcome results
None listed